Inventor · disambiguated record
Alan M. Fogelman
Also filed as: FOGELMAN ALAN M
25 granted patents·14 pending applications·558 citations·filing 2000–2017
97Inventor score
Files withUNIV CALIFORNIA27UNIV ALABAMA RES FOUND6FOGELMAN ALAN M4ANANTHARAMAIAH GATTADAHALLI M1UAB RESEARCH FOUNDATION1
Top patents by PatentIndex Score
39 records- 0195US7531514B2Orally administered peptides synergize statin activityUNIV CALIFORNIA·Filed 2006·Granted May 12, 2009·27 cites·26 claims
- 0294US8148328B2Salicylanilides enhance oral delivery of therapeutic peptidesFOGELMAN ALAN M·Filed 2007·Granted Apr 3, 2012·23 cites·23 claims
- 0394US7723303B2Peptides and peptide mimetics to treat pathologies characterized by an inflammatory responseUNIV CALIFORNIA·Filed 2006·Granted May 25, 2010·26 cites·29 claims
- 0494US7579319B2Methods for improving the structure and function of arteriolesUNIV CALIFORNIA·Filed 2005·Granted Aug 25, 2009·26 cites·17 claims
- 0594US6664230B1Orally administered peptides to ameliorate atherosclerosisUNIV CALIFORNIA·Filed 2000·Granted Dec 16, 2003·58 cites·61 claims
- 0693US7820784B2Orally administered peptides synergize statin activityUNIV CALIFORNIA·Filed 2007·Granted Oct 26, 2010·15 cites·17 claims
- 0793US7199102B2Orally administered peptides synergize statin activityUNIV CALIFORNIA·Filed 2003·Granted Apr 3, 2007·36 cites·67 claims
- 0893US7144862B2Orally administered peptides to ameliorate atherosclerosisUNIV ALABAMA RES FOUND·Filed 2002·Granted Dec 5, 2006·45 cites·48 claims
- 0993US6933279B2Orally administered peptides to ameliorate atherosclerosisUNIV CALIFORNIA·Filed 2001·Granted Aug 23, 2005·50 cites·48 claims
- 1092US8568766B2Peptides and peptide mimetics to treat pathologies associated with eye diseaseANANTHARAMAIAH GATTADAHALLI M·Filed 2008·Granted Oct 29, 2013·16 cites·24 claims
- 1192US7807640B2Orally administered peptides synergize statin activityUNIV CALIFORNIA·Filed 2007·Granted Oct 5, 2010·15 cites·21 claims
- 1291US7994132B2Peptides for treatment of sclerodermaUNIV CALIFORNIA·Filed 2007·Granted Aug 9, 2011·11 cites·20 claims
- 1390US7148197B2Orally administered small peptides synergize statin activityUNIV ALABAMA RES FOUND·Filed 2003·Granted Dec 12, 2006·30 cites·85 claims
- 1490US6869568B2Functional assay of high-density lipoproteinUNIV CALIFORNIA·Filed 2003·Granted Mar 22, 2005·38 cites·6 claims
- 1589US8048851B2Peptides and peptide mimetics to treat pathologies characterized by an inflammatory responseUNIV CALIFORNIA·Filed 2007·Granted Nov 1, 2011·10 cites·14 claims
- 1689US7166578B2Orally administered peptides synergize statin activityUNIV ALABAMA RES FOUND·Filed 2002·Granted Jan 23, 2007·37 cites·127 claims
- 1789US6930085B2G-type peptides to ameliorate atherosclerosisUNIV CALIFORNIA·Filed 2002·Granted Aug 16, 2005·30 cites·102 claims
- 1886US8236754B2Methods for improving the structure and function of arteriolesFOGELMAN ALAN M·Filed 2009·Granted Aug 7, 2012·8 cites·26 claims
- 1985US9539300B2Modulating disease through genetic engineering of plantsUNIV CALIFORNIA·Filed 2013·Granted Jan 10, 2017·1 cites·22 claims
- 2085US7250304B2Functional assay of high-density lipoproteinUNIV CALIFORNIA·Filed 2005·Granted Jul 31, 2007·11 cites·25 claims
- 2183US8404635B2Orally administered peptides synergize statin activityFOGELMAN ALAN M·Filed 2011·Granted Mar 26, 2013·4 cites·14 claims
- 2283US7723045B2Assays to predict atherosclerosis and dysfunctional high-density lipoproteinUNIV CALIFORNIA·Filed 2007·Granted May 25, 2010·9 cites·8 claims
- 2383US6596544B1Functional assay of high-density lipoproteinUNIV CALIFORNIA·Filed 2000·Granted Jul 22, 2003·21 cites·41 claims
- 2481US7638494B2G-type peptides to ameliorate atherosclerosisUNIV CALIFORNIA·Filed 2003·Granted Dec 29, 2009·11 cites·88 claims
- 2563US2013295042A1Peptides and Peptide Mimetics to Treat Pathologies Associated With Eye DiseaseUAB RESEARCH FOUNDATION·Filed 2013·Application pending·0 cites
- 2657US2007060527A1Orally administered small peptides synergize statin activityUNIV ALABAMA RES FOUND·Filed 2006·Application pending·0 cites
- 2756US2005164950A1Orally administered small peptides synergize statin activityUNIV CALIFORNIA·Filed 2004·Application pending·0 cites
- 2855US2008293639A1Peptides and peptide mimetics to treat pathologies characterized by an inflammatory responseUNIV CALIFORNIA·Filed 2007·Application pending·0 cites
- 2954US2017158751A1Modulating disease through genetic engineering of plantsUNIV CALIFORNIA·Filed 2016·Application pending·0 cites
- 3052US2006173067A1Small molecules for the treatment of atherosclerosisUNIV ALABAMA RES FOUND·Filed 2005·Application pending·0 cites
- 3151US10905736B2Ezetimibe-associated ApoA-I mimetic peptides showing enhanced synergismUNIV CALIFORNIA·Filed 2017·Granted Feb 2, 2021·0 cites·26 claims
- 3251US2006205669A1G-type peptides and other agents to ameliorate atherosclerosis and other pathologiesUNIV ALABAMA RES FOUND·Filed 2005·Application pending·0 cites
- 3351US2005187141A1Control of gene induced by oxidated lipids in human artery wall cellsUNIV CALIFORNIA·Filed 2005·Application pending·0 cites
- 3451US2011183889A1Salicylanilide modified peptides for use as oral therapeuticsUNIV CALIFORNIA·Filed 2008·Application pending·0 cites
- 3547US2003040505A1Synthetic phospholipids to ameliorate atherosclerosis and other inflammatory conditionsUNIV CALIFORNIA·Filed 2001·Application pending·0 cites
- 3646US2012004720A1G-type peptides and other agents to ameliorate atherosclerosis and other pathologiesFOGELMAN ALAN M·Filed 2011·Application pending·0 cites
- 3739US2010240598A1Peptides and peptide mimetics to inhibit the onset and/or progression of fibrotic and/or pre-fibrotic pathologiesUNIV CALIFORNIA·Filed 2010·Application pending·0 cites
- 3836US2010227825A1Peptides and peptide mimetics to treat cancerUNIV CALIFORNIA·Filed 2010·Application pending·0 cites
- 3934US2017280761A1Method to concentrate apoa-1 mimetic peptides transgenically expressed in plantsUNIV CALIFORNIA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alan M. Fogelman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →